Par Health Recalls Argatroban Injection Nationwide Over Particulate Contamination

Par Health USA, LLC has initiated a voluntary nationwide recall of 22 lots of Argatroban Injection 250 mg/2.5 mL. The recall is due to the presence of particulate matter, including cellulose, polystyrene, and potentially stainless steel, found in certain lots. Argatroban Injection is an anticoagulant used for patients with or at risk for heparin-induced thrombocytopenia, and the contamination poses potential health risks.